KaloBios Pharma (KBIO) Terminates CEO Martin Shkreli
Tweet Send to a Friend
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced that on December 17, 2015 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


